Corewell Health-BAMF Health

Grand Rapids, Michigan 49503

0 studies enrolling now · 2 studies all time

What they study most

High Risk Neuroblastoma, Malignant Melanoma, Non-hodgkin Lymphoma, SCLC, Sarcoma

Studies at this site

• GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 — Stopped early
• Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma — Stopped early